Victor M. Moyo - Oct 2, 2023 Form 4 Insider Report for Onconova Therapeutics, Inc. (ONTX)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Mark Guerin, Attorney-in-Fact
Stock symbol
ONTX
Transactions as of
Oct 2, 2023
Transactions value $
$0
Form type
4
Date filed
10/27/2023, 04:41 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ONTX Stock Option (right to purchase) Award $0 +125K $0.00 125K Oct 2, 2023 Common Stock 125K $0.74 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest over 4 years, 25% on the first anniversary of the grant and thereafter in 36 equal monthly installments over the next 3 years.